Cristina Martinez-Molina

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Combination Therapy

Interstitial Lung Disease

Cross Sectional

Top Venues

Medicina (Kaunas, Lithuania)

Scientific reports

Journal of clinical medicine

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Anna Feliu Ribera, Hye Sang Park, Ana Juanes, Cesar Diaz-Torné, Silvia Vidal, Hèctor Corominas
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients? Journal of clinical medicine 13 (8) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Cristina Martinez-Molina, Anna Feliu Ribera, Hye Sang Park, Ana Juanes, Cesar Diaz-Torné, Silvia Vidal, Hèctor Corominas
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients? Journal of clinical medicine 13 (8) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Lucía Vallez-Valero, Ingrid Gasó-Gago, Ángel Marcos Fendian, Gemma Garrido-Alejos, Adrià Riera-Magallón, Adrián Plaza Diaz, Cristina Martinez-Molina, Maria Antonia Mangues, Hèctor Corominas
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. Clinical rheumatology (2023)